These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28441526)

  • 1. It's T Time for Normal Blood Vessels.
    Thienpont B; Lambrechts D
    Dev Cell; 2017 Apr; 41(2):125-126. PubMed ID: 28441526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the "blood-tumor" barrier improves immunotherapy.
    Manzur M; Hamzah J; Ganss R
    Cell Cycle; 2008 Aug; 7(16):2452-5. PubMed ID: 18719382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors.
    Johansson-Percival A; He B; Li ZJ; Kjellén A; Russell K; Li J; Larma I; Ganss R
    Nat Immunol; 2017 Nov; 18(11):1207-1217. PubMed ID: 28892469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells.
    Yang Q; Goding S; Hagenaars M; Carlos T; Albertsson P; Kuppen P; Nannmark U; Hokland ME; Basse PH
    Cancer Immunol Immunother; 2006 Jun; 55(6):699-707. PubMed ID: 16047144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of angiogenesis in cancer metastasis.
    Fidler IJ; Kumar R; Bielenberg DR; Ellis LM
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S58-66. PubMed ID: 9619272
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular normalization in immunotherapy: A promising mechanisms combined with radiotherapy.
    Liu Z; Zhao Q; Zheng Z; Liu S; Meng L; Dong L; Jiang X
    Biomed Pharmacother; 2021 Jul; 139():111607. PubMed ID: 33965730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils: important contributors to tumor progression and metastasis.
    Swierczak A; Mouchemore KA; Hamilton JA; Anderson RL
    Cancer Metastasis Rev; 2015 Dec; 34(4):735-51. PubMed ID: 26361774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Metastasis of Solid Organ Tumors in the Perioperative Period.
    Freeman J; Connolly C; Buggy D
    Int Anesthesiol Clin; 2016; 54(4):29-47. PubMed ID: 27648889
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor angiogenesis: review of current applications in tumor prognostication.
    Weidner N
    Semin Diagn Pathol; 1993 Nov; 10(4):302-13. PubMed ID: 7511250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor interactions with the vasculature: angiogenesis and tumor metastasis.
    Blood CH; Zetter BR
    Biochim Biophys Acta; 1990 Jun; 1032(1):89-118. PubMed ID: 1694687
    [No Abstract]   [Full Text] [Related]  

  • 11. The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy.
    Kidoya H; Kunii N; Naito H; Muramatsu F; Okamoto Y; Nakayama T; Takakura N
    Oncogene; 2012 Jul; 31(27):3254-64. PubMed ID: 22037214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis: tutorial on implications for imaging.
    Passe TJ; Bluemke DA; Siegelman SS
    Radiology; 1997 Jun; 203(3):593-600. PubMed ID: 9169673
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiogenic molecules and cancer metastasis.
    Kumar R; Fidler IJ
    In Vivo; 1998; 12(1):27-34. PubMed ID: 9575423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors.
    Lim DS; Kim JH; Lee DS; Yoon CH; Bae YS
    Cancer Immunol Immunother; 2007 Nov; 56(11):1817-29. PubMed ID: 17443323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer.
    Maione F; Giraudo E
    Methods Mol Biol; 2015; 1267():349-65. PubMed ID: 25636478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment.
    Peske JD; Woods AB; Engelhard VH
    Adv Cancer Res; 2015; 128():263-307. PubMed ID: 26216636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    De Palma M; Jain RK
    Immunity; 2017 May; 46(5):773-775. PubMed ID: 28514684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity and metastasis: in situ activation of protective T cells by virus modified cancer vaccines.
    Schirrmacher V
    Cancer Surv; 1992; 13():129-54. PubMed ID: 1423321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
    Plavetić ND; Letilović T; Vrbanec D
    Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.